Headache Research Library
New Research Explores Migraine and Opioids
Recent studies have shown that of people with migraine who take acute prescription medications, more than a third keep opioids on hand to relieve their attacks.“
Examining the experiences of patients with new daily persistent headache
Jessica Gautreaux, MD, reviews the first qualitative descriptive study on NDPH
Healthcare Provider Wellness During COVID-19
Dawn Buse, PhD, FAHS, discusses some of the challenges faced by healthcare providers during the pandemic and ways to prioritize self-care.
Brad Klein: Member Spotlight
Honoree Brad Klein, MD, MBA, FAHS, talks about the importance of advocacy and business acumen in headache medicine
Telemedicine in the Age of the COVID-19 Pandemic
An article recently published in Cephalalgia examines whether synchronous video-based telemedicine visits with specialists are feasible, and evaluates clinical effectiveness, patient perceptions, and other benefits of telemedicine visits for follow-up migraine care in a tertiary headache center.
Headache Clinic Workflows During the COVID-19 Pandemic
Telemedicine and precaution can provide relief safely, according to Nina Riggins, MD, Ph.D, and Rashmi Halker Singh, MD, FAHS, FAAN
Cluster Headache Patients Experience Interictal Symptoms in Addition to Pain
According to a new study published in Headache®, patients who live with cluster headache—characterized by excruciatingly painful attacks lasting 15-180 minutes — experience ongoing symptoms even between attacks.
MAST Study Identifies Most Bothersome Symptom (MBS) for Patients with Migraine
Among nausea, phonophobia, and photophobia, one of these symptoms are reported as the most bothersome symptoms (MBS) in individuals with migraine.
Breaking News: Eptinezumab-jjmr (VYEPTI™) Approved by FDA
Eptinezumab, the first intravenous treatment for migraine prevention, approved by the FDA
Options for Treating Refractory Pediatric Migraine
A recent paper in Headache® found that combining outpatient DHE infusion with interdisciplinary adjunctive care has promise as an effective treatment option for adolescents with refractory migraine.
The Future of Neuromodulation: Q&A
Michael L. Oshinsky, PhD, discusses how headache researchers can shape the future of neuromodulation
The Genetics of Migraine: Q&A
It is widely accepted that migraine has a genetic component. But the genetics of migraine and how the disease develops is not yet well understood.
Headache Specialists vs. Non-Headache Specialists for Pediatric Treatments: A Review
Management practices for children with migraine vary between headache specialists and non-headache specialists. But these differences need to be overcome in order to better serve headache patients.
Familial vs. Sporadic Migraine: Study Finds Little Difference
Research shows that migraine is a complex disease. There are suspicions that there is a considerable genetic component involved with migraine. It is unknown, however, if this plays a role in disease severity, leading researchers to compare familial and sporadic migraine.